Study Design. In vitro assessment of the effects of platelet-rich plasma on the extracellular matrix metabolism of porcine intervertebral disc cells.
The relatively few cells that reside in the anulus fibrosus (AF) and nucleus pulposus (NP) maintain intervertebral disc (IVD) matrix metabolism homeostasis. Although the regulatory mechanisms are not well understood, nutrition to the disc, cytokines, and growth factors are thought to play a role. 1, 2 Recent studies have shown that growth factors can upregulate the production of matrix molecules and also stimulate the accumulation of matrix constituents during culture. 3, 4 The stimulation of cell metabolism by growth factors positively affects the perturbation of matrix maintenance even when the biochemical and biomechanical properties of disc tissues are compromised. 5 A recent study showed that the injection of a growth factor into normal IVDs 6 and the discs in a rabbit disc degeneration model induced an increase in disc height, 7 suggesting that growth factors may have a therapeutic use in the treatment of IVD degeneration. In those cases of IVD degeneration that exhibit advanced pathologic changes, apoptosis of IVD cells 8 and structural defects, such as an anulus tear, can be observed.
Several growth factors have been shown to positively modulate the metabolism of IVD cells. Transforming growth factor-␤ (TGF-␤), insulin-like growth factor-1 (IGF-1), platelet-derived growth factor (PDGF), and epidermal growth factor (EGF) stimulate cell proliferation and proteoglycan (PG) synthesis in vitro. 9 -12 PDGF also reduces the rate of cell apoptosis. 11 More recently, Masuda et al 3 and Yoon et al 4 showed that bone morphogenetic protein-7 (BMP-7, also known as osteogenic protein-1, OP-1) and BMP-2 both enhance PG metabolism in IVD cells. Furthermore, as cited above, the injection of BMP-7 was effective in increasing the disc height of degenerated rabbit IVDs. 7 Therefore, the application of growth factors via direct injection of recombinant proteins into the NP or the AF may be an effective therapeutic approach in the treatment of IVD degeneration. For repair of larger defects, alternative therapeutic approaches, such as the insertion of functional cells or tissue-engineered IVD constructs cultured with growth factor supplementation, may prove helpful in treating lumbar disc disease biologically rather than by conventional surgery.
Platelet-rich plasma (PRP) is a fraction of plasma that can be produced by centrifugal separation of whole blood in the operating room. Because PRP contains multiple growth factors concentrated at high levels, 14 -17 PRP from patients is used as an autologous source of growth factors for soft tissue and bone repair in several clinical settings. 18 -29 A platelet contains the vast majority of biologically active molecules required for blood coagulation, such as adhesive proteins, coagulation factors and protease inhibitors, within cytoplasmic ␣-granules. 30 In addition to the factors that coagulate blood, growth factors such as TGF-␤, PDGF, EGF, vascular endothelial growth factor, and IGF-1 are released from ␣-granules 30, 31 when platelets are activated. These growth factors are known to increase collagen content, accelerate epithelial regeneration, promote angiogenesis, and ultimately improve wound healing in skin and periodontal tissue, 21, [32] [33] [34] as well as to stimulate IVD metabolism as described above.
Because growth factors found in PRP have been differently demonstrated to enhance the cell viability or the matrix metabolism of IVD cells, 9 -12 the authors hypothesized that PRP, as a highly concentrated natural cocktail of growth factors, is able to stimulate proliferation and extracellular matrix metabolism of IVD cells. The purpose of this study was to examine the effect of PRP on cell proliferation and matrix metabolism of porcine IVD cells cultured in vitro using the alginate bead culture system.
Materials and Methods
Animals: Blood and IVD Collection. Eight mini-pigs (Sinclair Research Center, Inc., Columbia, MO) were used to isolate PRP, platelet-poor plasma (PPP) and IVD cells with the approval of the authors' institutional Animal Care Committee. Animals were first anesthetized by subcutaneous injections of Telazol (4.4 mg/kg, Fort Dodge Animal Health, Fort Dodge, IA) and xylazine (2.2 mg/kg, Xyla-Ject, Phoenix Pharmaceuticals, Inc., St. Joseph, MO). Blood (55 mL) was drawn from the popliteal vein with a 14G needle into a 60-mL syringe treated with an anticoagulant, citrate dextrose solution (Boehringer Laboratories Inc., Norristown, PA). After collecting peripheral blood, the animals were killed by intravenously injecting supersaturated pentobarbital (Euthanasia B solution, Henry Schein Inc., Washington Port, NY) and the lumbar spinal columns (L1-L6) were dissected en bloc.
Preparation of PRP and PPP. PRP and PPP were isolated from fresh porcine blood (about 55 mL) using the SYMPHONY 2 Platelet Concentration System (DePuy Spine, Raynham, MA) according to the manufacturer's protocol. To facilitate clot formation and also eliminate the influence of the biologic effects of thrombin, both PRP and PPP were clotted by adding a 10% thrombin solution (vol/vol, 1,000 U/mL in 100 mmol/L CaCl 2 ) to yield a final thrombin concentration of 100 U/mL. Soluble PRP and PPP releasates from the clotted preparations were isolated by centrifugation (1,500g for 5 minutes) and cleared by ultra-filtration (0.22 m). The final soluble releasate preparations (equivalent to serum) of PRP and PPP were frozen at Ϫ80 C until used.
Isolation of IVD Cells. Porcine IVDs cells were separately isolated from both NP and AF tissues by sequential enzymatic digestion, essentially as previously described. 3 Because of the limitation of cell numbers from a single animal, tissues from two pigs were pooled. The outermost layer of the AF (about 0.5 mm) was sharply dissected and discarded to prevent the contamination of cells from ligaments surrounding the IVD. The NP and AF were bluntly separated, and cells were isolated from NP and AF tissues by sequential enzyme digestion with 0.4% pronase (EMD Bioscience, La Jolla, CA) for 1 hour, and 0.025% collagenase P (Roche Applied Science, Indianapolis, IN) and 0.001% deoxy-ribonuclease 2 (DNase 2, Sigma Chemical, St. Louis, MO) for 16 hours in a 5% CO 2 :95% air incubator at 37°C, as previously described.
35
Cell Culture in Alginate Beads. After several washes in DMEM/F12 media, the cells isolated from each IVD tissue were resuspended in 1.2% low-viscosity sterile pharmaceutical grade alginate (Keltone LV, a gift from ISP Alginate Inc., San Diego, CA) solution at 4 million cells/mL. 35 The cultures, containing 9 beads per well in a 24-well plate, were maintained in 400 L of complete medium [Dulbecco's modified Eagle medium and Ham's F-12 medium (DMEM/F12: Mediatech, Herndon, VA) containing 10% fetal bovine serum (FBS: Hyclone, Logan, UT), 25 g/mL ascorbic acid (Sigma Chemical), 360 g/mL L-glutamine (Mediatech), and 50 g/mL gentamicin (Invitrogen, Carlsbad, CA)] in a 5% CO 2 :95% air incubator. The media were changed daily.
Effects of PRP Releasate, PPP Releasate, and Fetal Bovine Serum (FBS). After 7 days of culture in complete medium, the cells were precultured in serum-free medium (SFM), which consisted of DMEM/F12 containing 25 g/mL ascorbic acid, 360 g/mL L-glutamine and 50 g/mL gentamicin, for 24 hours. The cells were then cultured for another 72 hours under four different conditions: SFM, FBS (10% FBS in SFM), 10% PPP (10% PPP releasate in SFM), or PRP (10% PRP releasate in the SFM). The cultures, containing 9 beads per well in a 24-well plate, were incubated in 800 L of each medium for 72 hours without changing the medium during the treatment period. A preliminary experiment demonstrated that the rate of incorporation of 35 S-sulfate into PG by cells cultured under these conditions was constant throughout the 72-hour treatment period (data not shown).
Measurement of DNA Content. To evaluate cellular proliferation after the 72-hour treatment period, the DNA content in alginate beads was determined using the bisbenzimidazole fluorescent dye (Hoechst 33258: Polysciences, Warrington, PA) method. 36 Standard curves were generated at the time of each measurement using known concentration of calf thymus DNA. These DNA values were used to normalize the value obtained from the following analyses.
Measurement of Proteoglycan Synthesis.
The incorporation of radiolabeled 35 S into sulfated proteoglycans was measured as an indicator of proteoglycan synthesis. During the last four hours of the 72-hour treatment period, the cells were cultured in the presence of 35 S-sulfate (final concentration: 20 Ci/mL; PerkinElmer Life and Analytical Sciences, Boston, MA). After the 72-hour treatments, the beads and culture media were collected and the cell-associated and the further removed matrix compartments (CM and FRM, respectively) were separated by dissolving the beads followed by mild centrifugation as previously described. 37 The CM fractions were extracted for 48 hours at 4°C with 4 mol/L guanidine-HCl in the presence of proteinase inhibitors. 38 The amount of radiolabeled 35 S-PGs in the CM and FRM fractions and in the medium was quantified by a rapid filtration assay following precipitation of the glycosaminoglycans with Alcian blue.
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Characterization of 35 S-Labeled Proteoglycan. The size of newly synthesized PGs was assessed using CL-2B sieve chromatography under dissociative conditions, as previously described. 37 The partition coefficient of PGs in each column fraction was calculated as follows; (
where V e represents the elution volume for each column fraction. Proportions of large (Kd ϭ 0.35-0.45) and small (Kd ϭ 0.7-0.8) PGs were calculated by using a Peak Fit v4.12 software (SeaSolve Software. Inc., Framingham, MA) that performs nonlinear least squares curve-fitting using the Marquardt-Levenberg algorithm to find the true absolute minimum value of the sum of the squared deviations.
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Measurement of Total PG Content. After dissolving the alginate beads, the matrix compartments (CM and FRM) were separated and further digested with papain (Sigma Chemical) at 60 C for 16 hours. 35 The total sulfated PG content was measured in each compartment using a modified dimethylmethylene blue dye-binding method 40 in the presence of 0.03% alginate. 41 The sum of the total sulfated PG contents of the CM and FRM was used to represent the total content of PG.
Measurement of Collagen Synthesis. The incorporation of radiolabeled proline into pepsin-resistant protein was measured as an indicator of collagen synthesis. During the last 16 hours of the 72-hour treatment period, the cultures were radiolabeled with L- [2,3,4,5- 3 H]-proline (final concentration: 50 Ci/mL; Amersham Biosciences Corp., Piscataway, NJ). After isolation, the CM, FRM, and medium fractions were digested with 0.5 mol/L acetic acid including pepsin (Sigma Chemical; 100 g/mL) at 4°C for 16 hours. An aliquot (25 L) of each sample and 125 L of 30% trichloroacetic acid (final concentration 25%; Sigma) were pipetted into a well of a 96-well MultiScreen filtration plate assembly with gentle agitation for one hour at 4 C. 42 The formed precipitate, which contained pepsin-resistant 3 H-labeled protein, was collected on the filter membrane and unincorporated 3 H-proline was removed by washing each well three times with 200 L of 10% trichloroacetic acid followed by vacuum filtration through the membrane. The membrane in each well was punched out into a scintillation vial with 500 L of dissolving buffer (2% SDS in 0.1 N NaOH solution) followed by gentle shaking overnight at 37°C and the radioactivity of samples counted after adding 2.5 mL of Hydrofluor scintillation fluid (National Diagnostics, Atlanta, GA). The types of newly synthesized collagens present in the CM, FRM, and medium fractions were assessed by SDS-PAGE fluorography, as previously reported. 
Results

DNA Content
To study the effect of PRP on cell proliferation, cells were treated with SFM, FBS, PPP, or PRP for 72 hours and the DNA content in alginate beads measured. In alginate beads containing NP cells, treatment with PRP resulted in a significant increase in DNA content when compared with the SFM condition (PRP: ϩ43% P Ͻ 0.001; vs. SFM, Figure 1 ). The increase in DNA content in the alginate beads containing PRP-treated NP cells was also significantly higher than those containing PPP-treated NP cells (PRP: ϩ20.9%, vs. PPP, P Ͻ 0.001).
In AF cells, PRP had a significant stimulatory effect on cell proliferation when compared with SFM condition Figure 1 . Effect of platelet-rich plasma (PRP) treatment on the DNA content of alginate beads containing nucleus pulposus (NP) and anulus fibrosus (AF) cells. After a 1-week preculture period followed by serum starvation for 24 hours, cells were then cultured for another 72 hours in four different conditions: serum-free media (SFM), fetal bovine serum (10% FBS in SFM), 10% platelet-poor plasma (10% PPP releasate in SFM), or PRP (10% PRP releasate in the SFM). After treatment, the cultures were harvested and the DNA content measured. The increase in DNA content in the alginate beads containing PRP-treated cells was significantly higher than those containing PPP-treated cells.
(PRP: ϩ53.7%, P Ͻ 0.01; vs. SFM). The DNA content of alginate beads containing PRP-treated AF cells was also significantly higher than those of the FBS-and PPP-treated AF cells (PRP: ϩ35.7% vs. FBS; ϩ28.5%, vs. PPP, both P Ͻ 0.001).
Proteoglycan Synthesis
The rates of PG synthesis by the FBS-, PPP-, and PRPtreated NP cells were all significantly higher than that by the SFM-treated NP cells, when expressed per microgram DNA (Figure 2) . Stimulation of PG synthesis was greatest in the case of PRP-treated NP cells (PRP: ϩ235%, P Ͻ 0.001, vs. SFM): the FBS and PPP treatments showed a lesser degree of stimulation (FBS: ϩ104%, P Ͻ 0.01; PPP: ϩ110%, P Ͻ 0.01, vs. SFM, Figure 2) . Importantly, the rate of PG synthesis by the PRP-treated NP cells was also significantly higher than those by the PPP-and FBS-treated NP cells (PRP: ϩ63.9% vs. FBS; ϩ59.3%, vs. PPP, both P Ͻ 0.01).
The effect of PRP on the AF cells was essentially the same as that on the NP cells. The addition of PRP significantly stimulated PG synthesis by AF cells (PRP: ϩ253%, P Ͻ 0.001, vs. SFM, Figure 2) . Treatment with FBS increased PG synthesis slightly (FBS: ϩ57%, P Ͻ 0.01, vs. SFM, Figure 2 ) while the effects of PPP treatment were not statistically significant. Importantly, PG synthesis by the PRP-treated AF cells was significantly higher than that by the PPP-and FBS-treated AF cells (PRP: ϩ124.1% vs. FBS; ϩ112.3%, vs. PPP, both P Ͻ 0.01). There were no significant differences in PG synthesis by the FBS-and PPP-treated AF cells. It should be noted that while PG synthesis was more strongly upregulated in the case of AF cells than of NP cells, the basal level of PG synthesis by AF cells in each condition was higher than the corresponding level by NP cells.
When the distribution of newly synthesized PGs was analyzed, the proportion of newly synthesized PGs retained in the CM of NP cells was significantly higher, and to a similar degree, in the FBS-, PPP-, and PRP-treated groups than in the SFM-treated groups (P Ͻ 0.01, Figure  3 ). PRP treatment of AF cells led to a greater increase in the proportion of newly synthesized PGs retained in the Figure 2 . Effect of platelet-rich plasma (PRP) treatment on proteoglycan (PG) synthesis by nucleus pulposus (NP) and anulus fibrosus (AF) cells cultured in alginate beads. During the last 4 hours of the 72-hour treatment period, the cells were radiolabeled with 35 S-sulfate (20 Ci/mL). The amount of radiolabeled 35 S-PGs in the CM extract, the FRM fraction, and the media were quantified as described in Materials and Methods. Proteoglycan synthesis in the PRP-treated NP and AF cells was significantly higher than that in the PPP-and FBS-treated cells. CM than other forms of treatment (PRP: vs. SFM, P Ͻ 0.001; vs. FBS, P Ͻ 0.01, vs. PPP, P Ͻ 0.05, Figure 3) .
Examination of the sizes of newly synthesized PGs revealed that in beads containing either NP or AF cells, 35 S-PGs in the CM and FRM consisted predominantly of two populations of PG molecules: large PGs (previously shown to be aggrecan) and small nonaggregating PGs (such as decorin, biglycan, etc.) (Figure 4 ). In the CM fraction of beads containing either NP or AF cells, treatment with PRP predominantly increased the relative amount of large PGs and correspondingly decreased the proportion of small nonaggregating PGs when compared with the groups treated with SFM, FBS, or PPP ( Figure  4 ). In the FRM fraction of beads containing either NP or AF cells, the proportion of the two molecules did not show a clear difference among all groups (Figure 4 ).
Proteoglycan Accumulation
Alginate beads cultured in the presence of 10% PRP accumulated significantly more PGs than beads cultured in the absence of PRP under most culture conditions. This was true for both types of IVD cells [(NP: ϩ41.8% vs. SFM, P Ͻ 0.001; ϩ21.3%, vs. FBS, not significant; ϩ27.4% vs. PPP; P Ͻ 0.01) (AF: 60.8% vs. SFM, P Ͻ 0.01; ϩ55.5%, vs. FBS, P Ͻ 0.001; ϩ35.3% vs. PPP, P Ͻ 0.01, Figure 5) ]. The addition of FBS for 72 hours did not show a stimulatory effect on PG accumulation in beads containing either NP or AF cells, whereas the addition of PPP led to a slight increase in the PG content in alginate beads containing NP cells (ϩ11.3%, vs. SFM, P Ͻ 0.05). No significant differences in the distribution of PG within the CM or FRM were observed ( Figure 5 ).
Collagen Synthesis
The rate of collagen synthesis by PRP-treated cells was remarkably higher than that by SFM-treated cells, when expressed per microgram DNA (PRP: NP, ϩ457.0%; AF, ϩ769.1%, vs. SFM; all P Ͻ 0.001, Figure 6 ), whereas FBS and PPP showed a more modest stimulatory effect (NP: FBS, ϩ156.7%, PPP, ϩ220.2%; all P Ͻ 0.001 AF: FBS, ϩ132.6%, PPP, ϩ158.0%; all P Ͻ 0.01, Figure 6 ). The stimulatory effect on collagen synthesis was marked in the case of PRP-treated cells when compared with FBSand PPP-treated cells (NP: PRP, ϩ273.6% vs. FBS; ϩ236.8% vs. PPP; P Ͻ 0.001 AF: PRP, ϩ117.0% vs. FBS; ϩ74% vs. PPP; P Ͻ 0.01). It should be noted that the magnitude of the response by AF cells to PRP treatment was larger than that by NP cells. Treatment with PPP stimulated collagen synthesis by NP cells to a greater extent than FBS treatment (P Ͻ 0.001, Figure 6 ). No significant treatment-related differences in the distribution of newly synthesized collagen within the medium, CM, or FRM were observed (data not shown). As seen in the case of rabbit AF cells cultured in alginate, AF cells in this study produced mainly Type II collagen. Treatment with PRP or PPP did not change the profile of collagens produced (data not shown).
Discussion
The results of this study demonstrate that PRP was an effective stimulator of cell proliferation, PG and collagen synthesis, as well as PG accumulation, by porcine NP and AF cells cultured in alginate beads. Although PRP had a moderate stimulatory effect on cell proliferation in both cell types, the stimulatory effects remain significant when the data were expressed per microgram DNA. The stimulatory effects of PRP were stronger than those of FBS or PPP at the same concentration. Interestingly, the magnitude of the PRP-induced stimulation in PG and collagen synthesis was greater in the case of AF cells than of NP cells. PRP treatment stimulated the distribution of newly synthesized PGs into the CM compartment by both cell types, but especially by AF cells, suggesting that newly synthesized PGs accumulate in the CM, which is more metabolically active, rather than in the more abundant but metabolically inactive FRM. Furthermore, the proportion of large PGs in the CM was increased with PRP treatment by both AF and NP cells, which suggests that PRP mainly stimulates the synthesis of large PGs, such as aggrecan. Therefore, PRP stimulates PG synthesis and accumulation by both NP and AF cells with enhancement of the chondrocytic phenotype.
Mini-pigs (1-1.5 years old), which were used in this study as a source of both IVD tissues and blood, provided enough IVD cells and PRP to perform experiments on several aspects of IVD cell metabolism. Because the cells from the NP at this age include notochordal cells that can have different metabolic characteristics, 43, 44 experiments on human cells should be performed to confirm the results obtained in this study. In addition, although autologous PRP is preferred to perform the experiments, because of the limitation of cell numbers that could be obtained from the IVD tissues from a single animal, cells from different animals were pooled to perform the experiments. For the same reason, the AF tissues were not separated into two regions, the inner and outer AF, which are reported to have differing biologic responses. [45] [46] [47] Further studies to elucidate differences in the biologic responsiveness of cells from different regions of the AF to PRP should be conducted. This notwithstanding, it should be noted that four different batches of PRP from individual animals were tested and yielded essentially similar results. Using human blood, further studies on the effects of donor age, length of storage and storage conditions of PRP, and biologic characteristic variability should be performed. Thrombin, which has been shown to have some biologic effects on cell metabolism, was used to form a clot in the preparation of PRP. 48 -51 In this study, PPP was also treated with thrombin in order to control for the effects of thrombin on cell proliferation and matrix metabolism. There are reports that the biologic behavior of IVD cells is affected at a lower oxygen tension 52, 53 and a low pH 54 condition that differ from the standard in vitro culture conditions that we used in these experiments. The effect of PRP, especially on human IVD cells, at different oxygen tensions and pH, should be further investigated.
The effect of PRP on PG and collagen synthesis was more pronounced in the case of AF cells than of NP cells. This differs from results obtained with OP-1, which showed a more pronounced stimulatory effect on NP cells. 3 It should also be noted that the effects of PRP were more pronounced on collagen synthesis, especially in the case of AF cells. Because the AF matrix is rich in collagen, this might suggest that PRP is a good candidate to induce AF regeneration. A more detailed analysis of growth factors contained in PRP might shed light on the mechanisms responsible for the varying effects of PRP in different tissues and the metabolism of different extracellular matrix molecules. In the future, the therapeutic use of PRP and/or a combination of growth factors that target the repair of a specific tissue or molecule might be possible.
Because tissue engineering is gaining acceptance as a therapeutic approach for the biologic repair of the IVD, another usage of PRP might be for in vitro tissue engineering purposes. 1, 55 Currently, most tissue engineering approaches involve the use of animal serum, such as FBS, during culture. From the regulatory standpoint, the use of autologous serum and/or PRP may gain favor as a source of growth factors and serum supplements.
The use of PRP as a local injection might be one practical approach to stimulate cells for tissue regeneration, as was shown to be effective in the case of a recombinant growth factor protein. 7 One limitation of the use of PRP as a local injection is the concentration of growth factors in the preparation. The concentration of TGF-␤, IGF-1, and PDGF in PRP is limited to approximately a range of 80 to 500 ng/mL. 14 -17 The amounts of growth factors in the injectable volume (1-2 mL) might be too low to induce the types of biologic effects that were observed when OP-1 was used at 2 g/IVD in the rabbit. 6 Although multiple growth factors might exhibit synergistic effects, the in vivo effects of injectable amounts of PRP should be tested in an experimental animal model.
The use of PRP has several advantages over the use of recombinant growth factors or products of animal origin. As a point of care approach, the autologous preparation of PRP avoids the complex regulatory pathway. In addition, safety issues, such as disease transmission and immunologic reaction, are of much less concern. As a consequence, the cost of using PRP will be considerably cheaper than that associated with the use of recombinant proteins.
Conclusion
PRP may prove useful as a culture supplement for tissue engineering or for the biologic repair of the intervertebral disc. The results of this study provide preliminary evidence for the possible clinical use of PRP to facilitate biologic disc repair. Further studies to confirm the efficacy and reproducibility of PRP in stimulating human IVD cell metabolism and its applicability to in vivo animal experiments should be performed to advance this simple and safe new approach to repair IVD tissue biologically.
Key Points
• Platelet-rich plasma is effective in stimulating cell proliferation and extracellular matrix metabolism of porcine intervertebral disc cells cultured in alginate beads.
• The magnitude of the stimulation by platelet-rich plasma was significantly greater than that by either fetal bovine serum or platelet-poor plasma.
• The response to platelet-rich plasma was greater in the case of anulus fibrosus cells than of nucleus pulposus cells.
• The results raise the possibility of using plateletrich plasma as a culture supplement for tissue engineering or as a local injection to stimulate intervertebral disc repair.
